Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Nucleotide (guanine) analog, prevents guanine s...
JAK2 inhibitor.
Tetracycline; protein translation inhibitor, MM...
ITC found in cruciferous vegetables, analog of ...
EGFR inhibitor.
PORCN inhibitor.
Akt inhibitor.
Diarylether; bacterial ENR binder, fatty acid s...
Furocoumarin; voltage-gated Na+ channel blocker...
Cyclosporin metabolite; weak calmodulin inhibit...
Hydrazine; L-amino acid decarboxylase inhibitor...
ATP competitive CDK inhibitor.
Fatty acid synthase inhibitor.
KRAS inhibitor
Neutrophil elastase inhibitor.
Steroid; glucocorticoid agonist.
Neuroactive mycotoxin produced by Penicillum an...
Synthetic steroid, contraceptive; PR and glucoc...
Inhibitor of Abl, c-Kit, and PDGFR.